| – |
The European Medicines Regulatory System and the Role of the EMEA
|
| |
• |
Arielle North, EMEA |
| |
|
|
| – |
The new Legislation on Clinical Trials |
| |
• |
António Faria Vaz, INFARMED |
| |
|
|
| – |
Pharmacovigilance and Risk Management Strategies |
| |
• |
Xavier Kurz, Directorate-General Public Health Protection Medicinal Products, Belgium |
| |
|
|
| – |
Development of Paediatric Medicines |
| |
• |
Beatriz Lima, INFARMED |
| |
|
|
| – |
Update on New Therapies for Neurological Diseases |
| |
• |
Cristina Sampaio, INFARMED |
| |
|
|